Pulmatrix, Inc. financial data

Symbol
PULM on Nasdaq
Industry
Pharmaceutical Preparations
Location
945 Concord Street, Suite 1217, Framingham, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Ruthigen, Inc. (to 6/16/2015)
Latest financial report
10-K - Q4 2024 - Mar 21, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 765 % +22.3%
Debt-to-equity 29.6 % -47.6%
Return On Equity -73.3 % -14.6%
Return On Assets -56.5 % -38.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.65M shares 0%
Common Stock, Shares, Outstanding 3.65M shares 0%
Entity Public Float 7.05M USD -28%
Weighted Average Number of Shares Outstanding, Basic 3.65M shares +0.01%
Weighted Average Number of Shares Outstanding, Diluted 3.65M shares +0.01%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 7.81M USD +6.96%
Research and Development Expense 7.17M USD -53.8%
General and Administrative Expense 7.79M USD +19.4%
Operating Income (Loss) -9.76M USD +33.8%
Nonoperating Income (Expense) 204K USD -67%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -9.56M USD +32.3%
Earnings Per Share, Basic -2.62 USD/shares +32.3%
Earnings Per Share, Diluted -2.62 USD/shares +32.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.52M USD -50.3%
Accounts Receivable, after Allowance for Credit Loss, Current 23K USD -97.3%
Assets, Current 9.92M USD -52.4%
Property, Plant and Equipment, Net 1.11M USD +446%
Operating Lease, Right-of-Use Asset 10.1M USD +1374%
Other Assets, Noncurrent 13K USD -92.6%
Assets 9.94M USD -70.7%
Accounts Payable, Current 809K USD -57.8%
Employee-related Liabilities, Current 12K USD -98.3%
Liabilities, Current 929K USD -76.2%
Operating Lease, Liability, Noncurrent 8.23M USD
Liabilities 996K USD -93.8%
Retained Earnings (Accumulated Deficit) -297M USD -3.32%
Stockholders' Equity Attributable to Parent 8.95M USD -50.3%
Liabilities and Equity 9.94M USD -70.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.72M USD +44.8%
Net Cash Provided by (Used in) Financing Activities 53K USD
Net Cash Provided by (Used in) Investing Activities -154K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 3.65M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.87M USD +41.1%
Deferred Tax Assets, Valuation Allowance 26.5M USD +8.15%
Deferred Tax Assets, Gross 26.5M USD -2.99%
Operating Lease, Liability 24K USD -93.3%
Payments to Acquire Property, Plant, and Equipment 154K USD
Lessee, Operating Lease, Liability, to be Paid 24K USD -93.3%
Property, Plant and Equipment, Gross 2.9M USD -2.68%
Operating Lease, Liability, Current 24K USD -93.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.37M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.33M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +35.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.62M USD +46742%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.4M USD
Preferred Stock, Shares Authorized 500K shares 0%
Unrecognized Tax Benefits 644K USD +27.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.44M USD
Operating Lease, Payments 681K USD -80.3%
Additional Paid in Capital 306M USD +0.17%
Depreciation, Depletion and Amortization 59K USD +84.4%
Share-based Payment Arrangement, Expense 511K USD -46.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%